The current findings and potential applications of breast cancer epigenetics

Yen-Vy Nguyen Thi1, Quy Do Van2, Hai Linh Duong Nguyen2

  • 1The Interdisciplinary Research Group on Biomedicine and Health, International School, Vietnam National University, Hanoi, Vietnam; Faculty of Applied Sciences, International School, Vietnam National University, Hanoi, Vietnam.

Insights

Epigenetic modifications are key drivers in breast cancer development and progression. Targeting these epigenetic mechanisms offers a promising therapeutic strategy for improved diagnosis, prognosis, and non-invasive early detection.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Breast cancer is a leading global cancer, with gene mutations playing a significant role.
  • Epigenetic modifications are increasingly recognized as major contributors to breast cancer development and progression.

Purpose of the Study:

  • To explore the role of epigenetics in breast cancer development and progression.
  • To highlight the therapeutic potential of targeting epigenetic regulatory mechanisms.
  • To investigate epigenetic applications in improving breast cancer diagnosis, prognosis, and treatment.

Main Methods:

  • Review of recent molecular biology and epigenetic studies on breast cancer.
  • Analysis of epigenetic modifications' impact on gene activity and tumor progression.
  • Evaluation of epigenetic research for diagnostic and therapeutic advancements.

Main Results:

  • Epigenetic modifications are crucial in the development and progression of breast cancer.
  • Targeting epigenetic mechanisms can inhibit tumor progression and restore normal gene activity.
  • Epigenetics offers potential for improved breast cancer diagnosis, prognosis, and treatment.

Conclusions:

  • Epigenetic research significantly advances the understanding and management of breast cancer.
  • Targeting epigenetics presents a viable therapeutic strategy for breast cancer.
  • Epigenetics opens new avenues for early, non-invasive breast cancer detection.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.3K
Epigenetic Regulation01:46

Epigenetic Regulation

26.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K